Clinical Trial

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, observational clinical study aimed at evaluating the efficacy of Megestrol Acetate for cachexia in patients with advanced digestive system tumors receiving TKI-based therapy.
Trial Details
NCT Number NCT06940102
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Cachexia, Digestive System Cancer, Gastric Cancer, Colorectal Cancer, Hepatocellular Carcinoma
Enrollment 120 participants
Start Date 2025-03-12
Primary Completion 2026-03 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-23